+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
179334-20-4,MFCD00474647
Catalog No.:AA0026VI

179334-20-4 | 1-(4-Bromophenylsulfonyl)piperazine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$31.00   $22.00
- +
5g
98%
in stock  
$75.00   $53.00
- +
25g
98%
in stock  
$202.00   $142.00
- +
100g
98%
in stock  
$567.00 $397.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0026VI
Chemical Name:
1-(4-Bromophenylsulfonyl)piperazine
CAS Number:
179334-20-4
Molecular Formula:
C10H13BrN2O2S
Molecular Weight:
305.1914
MDL Number:
MFCD00474647
SMILES:
Brc1ccc(cc1)S(=O)(=O)N1CCNCC1
Properties
Computed Properties
 
Complexity:
314  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.1  

Downstream Synthesis Route

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2007/39580,2007,A1Locationinpatent:Page/Pagecolumn34

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2007/39581,2007,A1Locationinpatent:Page/Pagecolumn29

27018-76-4    179334-20-4   
(1-benzyl-1H-indol-3-yl)(4-((4-bromophenyl)sulfonyl)piperazin-1-yl)methanone 

[1]MedChemComm,2016,vol.7,p.1759-1767

[1]Singh,Anju;Kalamuddin,Md;Maqbool,Mudasir;Mohmmed,Asif;Malhotra,Pawan;Hoda,Nasimul[BioorganicChemistry,2021,vol.108]

179334-20-4    254732-51-9   
C19H16BrF3N4O2S 

[1]Cheng,Yao;Hu,Jianda;Wang,Lingyan;Wang,Rui;Wang,Wenfeng;Wang,Xucheng;Yuan,Yaofeng;Zhang,Min[JournaloftheIndianChemicalSociety,2022,vol.99,#5]

[2]Cheng,Yao;Hu,Jianda;Wang,Lingyan;Wang,Rui;Wang,Wenfeng;Wang,Xucheng;Yuan,Yaofeng;Zhang,Min[JournaloftheIndianChemicalSociety,2022,vol.99,#5]

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 179334-20-4
14172-55-5

14172-55-5

 179051-76-4

179051-76-4

 888181-08-6

888181-08-6

 385404-09-1

385404-09-1

 486422-26-8

486422-26-8

 349398-79-4

349398-79-4
Building Blocks
More >
Historical Records
13184-86-6

13184-86-6

 845989-03-9

845989-03-9

 879579-59-6

879579-59-6

 928956-43-8

928956-43-8

 37041-27-3

37041-27-3
Tags:179334-20-4 Molecular Formula|179334-20-4 MDL|179334-20-4 SMILES|179334-20-4 1-(4-Bromophenylsulfonyl)piperazine
Catalog No.: AA0026VI
179334-20-4,MFCD00474647
179334-20-4 | 1-(4-Bromophenylsulfonyl)piperazine
Pack Size： 1g
Purity： 98%
in stock
$31.00 $22.00
Pack Size： 5g
Purity： 98%
in stock
$75.00 $53.00
Pack Size： 25g
Purity： 98%
in stock
$202.00 $142.00
Pack Size： 100g
Purity： 98%
in stock
$567.00 $397.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0026VI
Chemical Name: 1-(4-Bromophenylsulfonyl)piperazine
CAS Number: 179334-20-4
Molecular Formula: C10H13BrN2O2S
Molecular Weight: 305.1914
MDL Number: MFCD00474647
SMILES: Brc1ccc(cc1)S(=O)(=O)N1CCNCC1
Properties
Complexity: 314  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 16  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.1  
Downstream Synthesis Route
108-24-7    179334-20-4    486422-26-8 

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2007/39580,2007,A1Locationinpatent:Page/Pagecolumn34

[2]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2007/39581,2007,A1Locationinpatent:Page/Pagecolumn29

27018-76-4    179334-20-4   
(1-benzyl-1H-indol-3-yl)(4-((4-bromophenyl)sulfonyl)piperazin-1-yl)methanone 

[1]MedChemComm,2016,vol.7,p.1759-1767

132-60-5    179334-20-4    2727251-27-4 

[1]Singh,Anju;Kalamuddin,Md;Maqbool,Mudasir;Mohmmed,Asif;Malhotra,Pawan;Hoda,Nasimul[BioorganicChemistry,2021,vol.108]

179334-20-4    254732-51-9   
C19H16BrF3N4O2S 

[1]Cheng,Yao;Hu,Jianda;Wang,Lingyan;Wang,Rui;Wang,Wenfeng;Wang,Xucheng;Yuan,Yaofeng;Zhang,Min[JournaloftheIndianChemicalSociety,2022,vol.99,#5]

[2]Cheng,Yao;Hu,Jianda;Wang,Lingyan;Wang,Rui;Wang,Wenfeng;Wang,Xucheng;Yuan,Yaofeng;Zhang,Min[JournaloftheIndianChemicalSociety,2022,vol.99,#5]

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Related Products of of 179334-20-4
14172-55-5
14172-55-5
179051-76-4
179051-76-4
888181-08-6
888181-08-6
385404-09-1
385404-09-1
486422-26-8
486422-26-8
349398-79-4
349398-79-4
Building Blocks More >
179688-27-8
179688-27-8
Ethyl 4,5-bis(2-methoxyethoxy)-2-aminobenzoate
AA002748 | MFCD11618122
18328-11-5
18328-11-5
4-Phenylbutyraldehyde
AA0027E6 | MFCD00800383
20173-98-2
20173-98-2
1H-Pyrazole, 1-ethenyl-
AA0027QJ | MFCD02823860
202208-73-9
202208-73-9
4-(3-Ethoxyphenyl)benzoic acid
AA00281U | MFCD03426474
202865-57-4
202865-57-4
1-Bromo-2,5-dichloro-3-fluorobenzene
AA0028EX | MFCD00142585
20320-44-9
20320-44-9
2-(Piperidin-1-ylcarbonyl)benzoic acid
AA0028NV | MFCD00443957
203626-46-4
203626-46-4
4,8-Dichloro-2,6-dimethylquinoline
AA0028XS | MFCD00272448
2040-14-4
2040-14-4
2'-Methylpropiophenone
AA00295O | MFCD05663689
204384-26-9
204384-26-9
4-(4-Fluorophenyl)-1h-pyrazole
AA0029E1 | MFCD12131135
20491-92-3
20491-92-3
2,4,6-Trimethoxyphenol
AA0029P2 | MFCD00017159
Historical Records
13184-86-6
13184-86-6
845989-03-9
845989-03-9
879579-59-6
879579-59-6
928956-43-8
928956-43-8
37041-27-3
37041-27-3
Submit
© 2017 AA BLOCKS, INC. All rights reserved.